Migraine Global Clinical Trials Review, H2, 2017

GlobalData's clinical trial report, “Migraine Global Clinical Trials Review, H2, 2017" provides an overview of Migraine clinical trials scenario. This report provides top line data relating to the clinical trials on Migraine. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Merck & Co Inc

GlaxoSmithKline Plc

Allergan Plc

Johnson & Johnson

Dr. Reddy's Laboratories Ltd

Teva Pharmaceutical Industries Ltd

Pfizer Inc

AstraZeneca Plc

Eli Lilly and Co

Banyan Group Inc

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Migraine to Central Nervous System Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Migraine to Central Nervous System Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 26

In Progress Trials by Phase 27

Clinical Trials by Trial Status 28

Clinical Trials by End Point Status 30

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Migraine Therapeutics Clinical Trials 35

Prominent Drugs 37

Latest Clinical Trials News on Migraine 38

Nov 29, 2017: The New England Journal of Medicine Publishes Data from Pivotal Phase III Trial of Fremanezumab for the Preventive Treatment of Chronic Migraine 38

Nov 29, 2017: Aimovig (erenumab) Phase 3 STRIVE Data Published In The New England Journal Of Medicine Demonstrate Significant, Sustained Efficacy In Migraine Prevention 38

Nov 29, 2017: Allergans Migraine Leadership Recognized with Enrico Greppi Award for Excellence in Headache Research 39

Nov 28, 2017: Axsome Therapeutics Announces AXS-07 for the Treatment of Migraine 40

Nov 27, 2017: Biohaven Completes Enrollment In Second Pivotal Phase 3 Clinical Trial Of Oral CGRP-Receptor Antagonist Rimegepant 41

Nov 20, 2017: Biohaven Receives Agreement From FDA on Initial Pediatric Study Plan for Rimegepant, a Second Generation Oral CGRP-Receptor Antagonist for the Acute Treatment of Migraine 42

Nov 16, 2017: Biohaven Completes Enrollment In The First Of Two Pivotal Phase 3 Clinical Trials Of Rimegepant, A Second Generation Oral CGRP-Receptor Antagonist, For The Acute Treatment Of Migraine 42

Nov 15, 2017: Promius Pharma Announces ZEMBRACE SymTouch (Sumatriptan Injection) 3 mg Achieves Primary Endpoint in Post-Approval Clinical Trial 42

Nov 08, 2017: Zosano Pharma Announces Initiation of Long-Term Safety Study for M207 as an Acute Treatment of Migraine 43

Oct 31, 2017: Impel NeuroPharma Announces First Patient Dosed in Phase 1 Clinical Trial of INP104 for Treatment of Acute Migraine Headache 43

Oct 23, 2017: BOTOX injections may provide relief for children and teens with hard-to-treat migraines 44

Oct 12, 2017: Zosano Announces Publication of Pivotal Data of ADAM Zolmitriptan for the Acute Treatment of Migraine in Cephalalgia 44

Oct 11, 2017: Trevena Announces Update on Development Plans for Migraine Drug Candidate TRV250 45

Clinical Trial Profile Snapshots 46

Appendix 644

Abbreviations 644

Definitions 644

Research Methodology 645

Secondary Research 645

About GlobalData 646

Contact Us 646

Source 647

List of Tables

Migraine Therapeutics, Global, Clinical Trials by Region, 2017* 8

Migraine Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Migraine Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11

Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12

Migraine Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13

Migraine Therapeutics Clinical Trials, North America, Top Countries, 2017* 14

Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15

Migraine Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 16

Proportion of Migraine to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 17

Migraine Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19

Migraine Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20

Proportion of Migraine to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 22

Migraine Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24

Migraine Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25

Migraine Therapeutics, Global, Clinical Trials by Phase, 2017* 26

Migraine Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27

Migraine Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28

Migraine Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30

Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31

Migraine Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32

Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33

Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35

Migraine Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List of Figures

Migraine Therapeutics, Global, Clinical Trials by Region (%), 2017* 8

Migraine Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Migraine Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11

Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12

Migraine Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13

Migraine Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14

Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15

Migraine Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 16

Proportion of Migraine to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 17

Migraine Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19

Migraine Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20

Proportion of Migraine to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 22

Migraine Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24

Migraine Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25

Migraine Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26

Migraine Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27

Migraine Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28

Migraine Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30

Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31

Migraine Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32

Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33

Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35

Migraine Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

GlobalData Methodology 645

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports